清肝健脾散结方治疗痰湿阻结型儿童睑板腺囊肿疗效观察及对肠道菌群的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R276.7;R729

基金项目:

广东省中医药局科研项目(20232010)


Observation on Clinical Efficacy of Qinggan Jianpi Sanjie Prescription in the Treatment of Pediatric Chalazion of Blended Phlegm-Damp Stagnation Type and Its Effect on Gut Microbiota
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清肝健脾散结方治疗痰湿阻结型儿童睑板腺囊肿的临床疗效,分析中药治疗前后患儿的肠道菌群特征,探讨睑板腺囊肿与肠道菌群的相关性。方法:选取2023年1月—2025年3月广东省妇幼保健院就诊的痰湿阻结型睑板腺囊肿儿童60例,按随机数字表法分为治疗组和对照组各30例。治疗组在常规西医对症支持治疗基础上口服清肝健脾散结方,对照组仅予常规西医治疗,疗程均为14天。记录治疗前后最大囊肿最长径、中医证候评分,随访半年观察复发情况;另纳入13例正常儿童作为健康组,收集治疗前后治疗组(19例) 及健康组粪便标本,提取DNA后通过二代测序检测肠道菌群16S rRNA序列,分析菌群结构特征。结果:治疗后,治疗组总有效率为90.00% (27/30),对照组为66.67% (20/30),组间比较,差异有统计学意义(P<0.05)。治疗后,2 组最大囊肿长径均较治疗前缩短(P<0.05),且治疗组最大囊肿长径短于对照组(P<0.05)。治疗后,2组中医证候评分均较治疗前降低(P<0.05),治疗组中医证候评分低于对照组,但组间比较差异无统计学意义(P>0.05)。随访后6 个月, 治疗组复发率为22.22% (6/27), 对照组为45.00%(9/20),2 组比较,差异无统计学意义(P>0.05)。治疗组优势菌门排序前3是厚壁菌门、拟杆菌门、放线菌门,治疗前相对丰度分别为40.95%、40.31%、11.90%;治疗后分别为43.90%、39.21%、10.96%。健康组优势菌门前3是厚壁菌门、拟杆菌门、变形菌门,相对丰度分别为34.69%、33.85%、18.38%。健康组、治疗组治疗前、治疗组治疗后Shannon指数比较,差异无统计学意义(P>0.05)。β多样性分析显示:治疗组治疗前群落结构与健康组比较,差异有统计学意义(P<0.05);治疗组治疗后群落结构与健康组比较,差异无统计学意义(P>0.05)。3组间物种相对丰度比较,在种水平方面,Bacteroides_acidifaciens 相对丰度在治疗组治疗前高于健康组(P<0.05),治疗组治疗后与健康组比较差异无统计学意义(P>0.05)。将相对丰度前30的菌属用R包randomForest绘制物种重要性点图,结果显示拟杆菌属(Bacteroides) 排在首位,但Bacteroides 相对丰度在治疗组治疗前与健康组无明显差异(P>0.05),治疗组治疗后则高于健康组(P<0.05)。在属水平方面, 差异菌属Acetobacter 在健康组中丰度极低, 接近未检出; 治疗组在治疗前后筛选出的差异菌属为Alloprevotella、Prevotellaceae_NK3B31_group,但未检索到这些菌属与睑板腺囊肿有直接关联的文献。结论:清肝健脾散结方能缩小睑板腺囊肿、改善中医证候,治疗后患儿肠道菌群结构接近正常儿童,具体差异菌属的临床价值需进一步研究证实。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Qinggan Jianpi Sanjie Prescription in the treatment of pediatric chalazion of blended phlegm-damp stagnation type,analyze the gut microbiota characteristics before and after Chinese medicine treatment,and explore the correlation between chalazion and gut microbiota. Methods:A total of 60 children with chalazion of blended phlegm-damp stagnation type treated at Guangdong Women and Children Hospital from January 2023 to March 2025 were randomly divided into the treatment group and the control group using the random number table method, with 30 cases in each group. The treatment group was administered Qinggan Jianpi Sanjie Prescription orally on the basis of conventional western medicine symptomatic treatment, while the control group received conventional western medicine alone. The treatment duration was 14 days. The maximum diameter of the largest cyst and traditional Chinese medicine syndrome scores were recorded before and after treatment, with a six-month follow-up for recurrence. Additionally,13 normal children were recruited as the healthy group. Fecal samples from the treatment group (19 cases) and from the healthy group were collected. DNA was extracted,and 16S rRNA sequencing of gut microbiota was performed using next-generation sequencing to analyze the structural characteristics of the microbiota. Results: After treatment, the total effective rate was 90.00% (27/30) in the treatment group and 66.67%( 20/30) in the control group,with a statistically significant difference between the two groups( P<0.05). After treatment,the maximum diameter of the largest cyst decreased in both groups compared with that before treatment (P< 0.05),and the maximum diameter in the treatment group was smaller than that in the control group (P<0.05). After treatment, the traditional Chinese medicine syndrome scores decreased in both groups compared with those before treatment (P<0.05). The traditional Chinese medicine syndrome score in the treatment group was lower than that in the control group,but the difference was not statistically significant (P>0.05). After six-month follow-up,the recurrence rate was 22.22%( 6/27) in the treatment group and 45.00%( 9/20) in the control group,with no statistically significant difference between the two groups (P>0.05). In the treatment group, the top three dominant phyla were Firmicutes (40.95% before treatment, 43.90% after treatment), Bacteroidetes (40.31% before treatment, 39.21% after treatment), and Actinobacteria (11.90% before treatment, 10.96% after treatment). In the healthy group, the top three dominant phyla were Firmicutes (34.69%),Bacteroidetes (33.85%),and Proteobacteria (18.38%). There was no significant difference in Shannon index among the healthy group, the pre-treatment group, and the posttreatment group (P>0.05). Beta diversity analysis revealed a significant difference in microbiota structure between the pre-treatment group and the healthy group (P<0.05), while no obvious difference was observed between the posttreatment group and the healthy group (P>0.05). At the species level, the relative abundance of Bacteroides Facidifaciens was higher in the pre-treatment group than in the healthy group (P<0.05),and there was no significant difference between the post-treatment group and the healthy group (P>0.05). A randomForest plot of the top 30 genera in relative abundance, generated using the R package, showed that Bacteroides ranked first. However, the relative abundance of Bacteroides was not significantly different between the pre-treatment group and the healthy group (P> 0.05),but was higher in the post-treatment group than in the healthy group (P<0.05). At the genus level,Acetobacter had a very low abundance (nearly undetectable) in the healthy group. The differential genera identified before and after treatment in the treatment group were Alloprevotella and Prevotellaceae_NK3B31_group, but no literature directly linking these genera to chalazion was found. Conclusion: Qinggan Jianpi Sanjie Prescription can reduce the size of chalazion and improve traditional Chinese medicine syndrome manifestations. After treatment, the gut microbial structure of affected children becomes similar to that of healthy individuals. The clinical significance of specific differential genera requires further investigation.

    参考文献
    相似文献
    引证文献
引用本文

刘嘉芬,高彩凤,刘秋慧,黄思敏.清肝健脾散结方治疗痰湿阻结型儿童睑板腺囊肿疗效观察及对肠道菌群的影响[J].新中医,2026,58(14):49-58

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-07-31
  • 出版日期:
文章二维码